Dow Down 0.25% Nasdaq Down 0.26%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.45 0.02(1.40%) Aug 28, 3:59PM EDT
Prev Close:1.43
Open:1.43
Bid:1.30 x 100
Ask:3.12 x 500
1y Target Est:5.00
Beta:1.41
Next Earnings Date:N/A
Day's Range:1.43 - 1.47
52wk Range:1.26 - 2.56
Volume:44,188
Avg Vol (3m):160,151
Market Cap:40.24M
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OPXA

Comparison

Symbol% ChgMkt Cap
OPXAUp 1.40%40.24M
SNY143.54B
TEVA44.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.56
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback